Thyroxine Sodium 0.025 mg Tab, Anti thymocytic globulin 250 mg (Equine) 5 ml Inj
Indian Army · Pharmaceuticals · open
Key facts
- Published: 24 Jul 2026
- Closing date: 14 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of Thyroxine Sodium 0.025 mg tablets and Anti thymocytic globulin 250 mg (Equine) 5 ml injections for the Indian Army, Ministry of Defence, Department of Military Affairs. Bid validity is 180 days from the end date, with a total quantity of 294870 units. The tender includes technical specifications, evaluation criteria, and procurement preferences for MII and MSE vendors.
Eligibility & requirements
- Experience required: 3 years
- Past performance: 20%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience Certificates, Turnover Certificates, OEM Authorization
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (2)
- Thyroxine Sodium 0.025 mg Tablet — Qty: 294870 Tablet
- Anti thymocytic globulin 250 mg (Equine) 5 ml Inj — Qty: 294870 Injection
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals